Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Pértega Gomes, Nelma ^a,b   Vizcaíno, José R ^c   Miranda Gonçalves, Vera ^a,b   Pinheiro, Céline ^a,b   Silva, Joana ^a,b   Pereira, Helena ^b   Monteiro, Pedro ^d   Henrique, Rui M ^e   Reis, Rui M ^a,b,f   Lopes, Carlos ^c   Baltazar, Fátima ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c Centro Hospitalar Universitario do Porto   (Portugal)

^d Universidade do Minho ^*  (Portugal)

^e PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^f BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 4; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN GP70; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; UPREGULATION;

EID: 79960587072     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-312     Document Type: Article

References (34)

1. Warburg O, Wind F, Neglein E. Metabolism of tumours in the body. J Gen Physiol 1927, 8:519-530. 10.1085/jgp.8.6.519, 2140820, 19872213.
2. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899. 10.1038/nrc1478, 15516961.
3. Izumi H, Torigoe T, Ishiguchi H, Uramoto H, Yoshida Y, Tanabe M, Ise T, Murakami T, Yoshida T, Nomoto M, Kohno K. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 2003, 29:541-549. 10.1016/S0305-7372(03)00106-3, 14585264.
4. Semenza GL, Artemov D, Bedi A, Bhujwalla Z, Chiles K, Feldser D, Laughner E, Ravi R, Simons J, Taghavi P, Zhong H. The metabolism of tumours: 70 years later. Novartis Found Symp 2001, 240:251-260.
5. Halestrap AP, Price NT. The proton-linked monocarboxylate transporter MCT. Family: structure, function and regulation. Biochem J 1999, 343:281-299. 10.1042/0264-6021:3430281, 1220552, 10510291.
6. Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA, Schmitt F, Baltazar F. Increased expression of monocarboxylate transporters 1, 2 and 4 in colorectal carcinomas. Virchows Arch 2008, 452:139-146. 10.1007/s00428-007-0558-5, 18188595.
7. Pinheiro C, Longatto-Filho A, Ferreira L, Pereira S, Etlinger D, Moreira M, Jubé L, Queiroz G, Schmitt F, Baltazar F. Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. Int J Gynec Pathol 2008, 27:568-574.
8. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami S, Rodeck U, Berd D, Leeper DB, Owen CS. Regulation of intracellular pH in human melanoma:potential therapeutic implications. Mol Cancer Ther 2002, 37:617-628.
9. Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 2010, 56:860-867. 10.1111/j.1365-2559.2010.03560.x, 20636790.
10. Pinheiro C, Reis RM, Ricardo S, Longatto-Filho A, Schmitt F, Baltazar F. Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol 2010, 2010:427694. Epub 2010 May 4, 2863082, 20454640.
11. Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E. Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumour associated stroma. Cancer Biol Ther 2007, 6:1476-1479. 10.4161/cbt.6.9.4635, 17881895.
12. Gomes N, Vizcaíno JR, Pinheiro C, Baltazar F. Monocarboxylate transporters 2 and 4 are upregulated in prostate carcinoma. Virchows Arch 2009, 455(Supplement: Suppl. 1):233.
13. Gomes N, Vizcaíno JR, Pinheiro C, Baltazar F. Characterization of monocarboxylate transporters expression in prostate carcinoma. Microsc Microanal 2009, 15(Supplement S3):17-18.
14. Hao J, Chen H, Madigan MC, Cozzi PJ, Beretov J, Xiao W, Delprado WJ, Russell PJ, Li Y. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDRI and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Br J Cancer 2010, 103(7):1008-1018. 10.1038/sj.bjc.6605839, 20736947.
15. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 2000, 19:3896-3904. 10.1093/emboj/19.15.3896, 306613, 10921872.
16. Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem 2005, 280:27213-27221. 10.1074/jbc.M411950200, 15917240.
17. Deora AA, Philp N, Hu J, Bok D, Rodriguez-Boulan E. Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia. Proc Natl Acad Sci USA 2005, 102:16245-16250. 10.1073/pnas.0504419102, 1283422, 16260747.
18. Gallagher SM, Castorino JJ, Wang D, Philp NJ. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 2007, 67:4182-4189. 10.1158/0008-5472.CAN-06-3184, 17483329.
19. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006, 56:359-367. 10.1111/j.1440-1827.2006.01972.x, 16792544.
20. Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005, 87:361-368. 10.1016/j.biochi.2004.09.023, 15781323.
21. Riethdorf S, Reimers N, Assmann V, Kornfeld JW, Terracciano L, Sauter G, Pantel K. High incidence of EMMPRIN expression in human tumors. Int J Cancer 2006, 19:1800-1810.
22. Zhao-Dong H, Xue-Cheng B, Wei-jun Q, He H, Dai Q, Zou J, Ye Y, Liang Y, Zeng G, Chen Z, Zhong W. CD147 Expression indicates unfavourable prognosis in prostate cancer. Pathol Oncol 2009, 15:369-374.
23. Zhong WD, Han ZD, He HC, Bi XC, Dai QS, Zhu G, Ye YK, Liang YX, Qin WJ, Zhang Z, Zeng GH, Chen ZN. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 2008, 75:230-236. 10.1159/000163852, 18852494.
24. Madigan MC, Kingsley EA, Cozzi PJ, Madigan MC, Kingsley EA, Cozzi PJ, Delprado W, Russel P, Li Y. The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression. Cancer Immunol Immunother 2008, 57:1367-1379. 10.1007/s00262-008-0473-x, 18273614.
25. Han ZD, He HC, Bi XC, Qin WJ, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Zhu G, Chen ZN, Zhong WD. Expression and clinical significance of CD147 in genitourinary carcinomas. J Surg Res 2010, 160:260-267. 10.1016/j.jss.2008.11.838, 19286191.
26. Epstein J, Allsbrook W, Amin M, Egevad LL, . ISUP Grading Committee The 2005 International Society of Urological Pathology (ISUP) Consensus conference on gleason grading of prostatic carcinoma. Am J Sur Pathol 2005, 29:1228-1242. ISUP Grading Committee.
27. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual 2010, Chicago:Springer, 7.
28. Damber JE, Aus G. Prostate cancer. Lancet 2008, 371:1710-1721. 10.1016/S0140-6736(08)60729-1, 18486743.
29. Mathupala SP, Parajuli P, Sloan AE. Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 2004, 55:1410-1419.
30. Sonveaux P, Vegran F, Schroeder T, Wergin M, Verrax J, Rabbani ZN, Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 2008, 118:3930-3942. 2582933, 19033663.
31. Slomiany MG, Grass GD, Robertson AD. Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res 2009, 69:1293-1301. 10.1158/0008-5472.CAN-08-2491, 19176383.
32. Legaspi A, Jeevanandam M, Starnes HF, Brennan MF. Whole body lipid and energy metabolism in the cancer patient. Metabolism 1987, 36:958-963. 10.1016/0026-0495(87)90132-6, 3657515.
33. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM. α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002, 62:2220-2226.
34. McClelland G, Khanna S, Brooks G. Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system?. Biochem Biophys Res Commun 2003, 304:130-135. 10.1016/S0006-291X(03)00550-3, 12705896.